Related Experiment Video
Updated: Aug 25, 2025

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
Has_circ_0010220 regulates the miR-574-3p/IL-6 axis to increase doxorubicin resistance in osteosarcoma
Yanglin Gu1, Guangchang Wang1, Baocai Ran2
1Department of Orthopedics, The Affiliated Wuxi No. 2 People's Hospital of Nanjing Medical University, Wuxi, Jiangsu, P.R. China.
Background:
Osteosarcoma (OS) is the most common primary bone malignancy. It has an aggressive nature and produces drug resistance in diseased patients, which in turn causes obstacles in treating cancer with chemotherapy. The objective of our investigation was to analyze the function and hsa_circ_0010220 mechanism in doxorubicin (DOX) resistance to OS.
Methods:
The hsa_circ_0010220, IL-6, and miR-574-3p levels in OS diseased tissues and cell resistance towards DOX drug were elucidated by qRT-PCR and Elisa assay. The DOX half-inhibitory concentration (IC50) was quantified by Cell Counting Kit-8. For this study, we used RNA pull-down, RNA immunoprecipitation, and a dual-luciferase reporter experiment to identify the proteins that interacted with has_circ_0010220, IL-6, and miR-574-3p in OS cells that have developed resistance towards DOX.
Results:
The results indicated upregulated Hsa_circ_0010220 and IL-6 expression, However, DOX-resistant OS tissues and cells showed a downregulation of miR-574-3p. Reducing DOX resistance in vitro was achieved by silencing Has_circ_0010220. Further, by sponging miR-574-3p, increasing has_circ_0010220 boosted DOX resistance. However, miR-574-3p bound to IL-6 and inhibited DOX resistance. Additionally, it was discovered that hsa_circ_0010220 sponged miR-574-3p for upregulating IL-6 expression.
Conclusions:
Hsa_circ_0010220 encouraged OS resistance to DOX by miR-574-3p/IL-6 axis regulation, suggesting its potency as a promising biomarker for treating OS.
Insights
Hsa_circ_0010220 promotes osteosarcoma (OS) drug resistance by regulating the miR-574-3p/IL-6 axis. Silencing hsa_circ_0010220 can reduce this resistance, highlighting its potential as a therapeutic biomarker.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Osteosarcoma (OS) is a primary bone cancer with aggressive behavior.
- Drug resistance, particularly to chemotherapy, presents a significant challenge in OS treatment.
- Understanding the molecular mechanisms underlying doxorubicin (DOX) resistance is crucial for developing effective therapies.
Purpose of the Study:
- To investigate the functional role of hsa_circ_0010220 in doxorubicin (DOX) resistance in osteosarcoma (OS).
- To elucidate the underlying molecular mechanism of hsa_circ_0010220 in mediating DOX resistance.
- To explore the potential of hsa_circ_0010220 as a biomarker for OS treatment.
Main Methods:
- Quantitative real-time PCR (qRT-PCR) and ELISA were used to measure hsa_circ_0010220, IL-6, and miR-574-3p levels.
- Cell Counting Kit-8 assay determined the half-inhibitory concentration (IC50) of DOX.
- RNA pull-down, RNA immunoprecipitation, and dual-luciferase reporter assays identified molecular interactions.
Main Results:
- Hsa_circ_0010220 and IL-6 were upregulated, while miR-574-3p was downregulated in DOX-resistant OS tissues and cells.
- Silencing hsa_circ_0010220 reduced in vitro DOX resistance.
- Hsa_circ_0010220 sponges miR-574-3p, leading to increased IL-6 expression and enhanced DOX resistance.
Conclusions:
- Hsa_circ_0010220 promotes OS resistance to DOX through the regulation of the miR-574-3p/IL-6 axis.
- Targeting hsa_circ_0010220 offers a potential therapeutic strategy for overcoming DOX resistance in OS.
- Hsa_circ_0010220 may serve as a promising biomarker for predicting and treating OS.
Related Concept Videos
Abnormal Proliferation
MicroRNAs
PI3K/mTOR/AKT Signaling Pathway
Induced Pluripotent Stem Cells
Somatic...
Treatment Resistant Cancers
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

